CrossrefInfokarte
Loss of LKB1 is Associated with Cisplatin Resistance in Oral Squamous Cell Carcinoma and Pharmacological Activation of the LKB1–AMPK Axis Attenuates the Resistant Phenotype
OncoTargets and Therapy · 2026-11 · Volume 19 · 1-15
DOI: 10.2147/ott.s645900 ↗Abstract
Kein Abstract verfügbar.
EUVIMED